Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Karatieieva S, Plesh I, Yurkiv O, Semenenko S, Kozlovskaya I
In the same study, Beyond the scale with Wegovy HD 1 Patients taking Wegovy HD pen 7.2 mg experienced improvements across most cardiometabolic risk factors Confirmatory secondary end points: Change from baseline to week 72 in 1 : Waist circumference: 5.6-inch reduction 2.2-inch reduction with placebo Supportive secondary end points: Change from baseline to week 72 in 1 : Lipid profile: Total cholesterol 3.4% reduction 4.0% reduction with placebo LDL 3.5% reduction 4.8% reduction with placebo HDL 9.5% increase 0.5% decrease with placebo Triglycerides 16.4% reduction 0.9% reduction with placebo Systolic blood pressure: 10.1 mm Hg reduction 4.8 mm Hg reduction with placebo Diastolic blood pressure: 4.5 mm Hg reduction 1.8 mm Hg reduction with placebo A1c: 0.3% reduction 0% change with placebo Safety end point: Change in 1 : Heart rate: 0.5 bpm increase 0.6 bpm reduction with placebo Wegovy is not indicated to treat hypertension, type 2 diabetes, or dyslipidemia
Our team will work closely with you to ensure that you are fully informed and comfortable with your treatment plan, empowering you to take an active role in your health and well-being
As mentioned earlier, these patches, which contain natural ingredients 3 , are said to work by activating the GLP-1 hormone, which might in turn reduce appetite and cravings and manage blood sugar level
